Consensus Solasia Pharma K.K. Deutsche Boerse AG

Equities

9SO

JP3436500007

Market Closed - Deutsche Boerse AG Other stock markets 15:50:00 2024-05-21 EDT			5-day change	1st Jan Change
0.14 ^EUR	0.00%		+3.70%	-47.76%

05-15	Solasia Pharma K.K. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending December 31, 2024	CI
03-04	Solasia Pharma K.K. announced that it has received KRW 504.33 million in funding from Macquarie Group Limited	CI

Evolution of the average Target Price on Solasia Pharma K.K.

Price target over the last 5 years

History of analyst recommendation changes

a0ab5272dabad417a0d6369ac44.GkxotTOk3JY8zAnG0CLAkn4B1inDTcK9xMbxZ4Ad4bc.LRw8jVH7kO5Upz-ejxr13FNl4hmgFLX2tqfFPrFpk_9ufSzFa-WR-lGfZg~6ee2626fc2e7f6aceb224c1ad68be3ef